Annexin Pharmaceuticals AB (publ)
| Position | Amount | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2021-01-07 | Annexin Pharmaceuticals AB (publ) | Nils Anders Haegerstrand | Chief Executive Officer (CEO)/Managing Directory | Acquisition | 164 761 | 0,32 | SEK | 52 723,52 | 2021-01-06 |
| 2021-10-26 | Annexin Pharmaceuticals AB (publ) | Lena Torlegård | Member of the Board of Directors | Subscription | 75 000 | 1,25 | SEK | 93 750 | 2021-10-24 |
| 2021-10-27 | Annexin Pharmaceuticals AB (publ) | Nils Anders Haegerstrand | Chief Executive Officer (CEO)/Managing Directory | Subscription | 150 000 | 1,25 | SEK | 187 500 | 2021-10-24 |
| 2021-10-27 | Annexin Pharmaceuticals AB (publ) | Henrik Palm | Chief Financial Officer (CFO) | Subscription | 75 000 | 1,25 | SEK | 93 750 | 2021-10-21 |
| 2021-11-03 | Annexin Pharmaceuticals AB (publ) | Carl-Fredrik Lindner | Member of the Board of Directors | Subscription | 60 000 | 1,25 | SEK | 75 000 | 2021-11-02 |
| 2022-03-17 | Annexin Pharmaceuticals AB (publ) | Uli Hacksell | Chairman of the Board of Directors | Acquisition | 100 000 | 0,869 | SEK | 86 900 | 2022-03-14 |
| 2022-06-17 | Annexin Pharmaceuticals AB (publ) | Nils Anders Haegerstrand | Chief Executive Officer (CEO)/Managing Directory | Acquisition | 300 000 | 0,21 | SEK | 63 000 | 2022-06-13 |
| 2023-12-18 | Annexin Pharmaceuticals AB (publ) | Carl-Fredrik Lindner | Member of the Board of Directors | Acquisition | 500 005 | 0,2 | SEK | 100 001 | 2023-12-14 |
| 2023-12-19 | Annexin Pharmaceuticals AB (publ) | Anna Frostegård | Other member of the company's administrative, management or supervisory body | Subscription | 2 910 622 | 0,2 | SEK | 582 124,4 | 2023-12-17 |
| 2023-12-19 | Annexin Pharmaceuticals AB (publ) | Nils Anders Haegerstrand | Chief Executive Officer (CEO)/Managing Directory | Acquisition | 635 008 | 0,2 | SEK | 127 001,6 | 2023-12-17 |
| 2023-12-20 | Annexin Pharmaceuticals AB (publ) | Uli Hacksell | Chairman of the Board of Directors | Allotment | 110 000 | 0,2 | SEK | 22 000 | 2023-12-13 |
| 2024-05-29 | Annexin Pharmaceuticals AB (publ) | Carl-Fredrik Lindner | Member of the Board of Directors | Acquisition | 399 997 | 0,25 | SEK | 99 999,25 | 2024-05-28 |
| 2024-05-29 | Annexin Pharmaceuticals AB (publ) | Nils Anders Haegerstrand | Chief Executive Officer (CEO)/Managing Directory | Subscription | 512 200 | 0,25 | SEK | 128 050 | 2024-05-27 |
| 2024-05-29 | Annexin Pharmaceuticals AB (publ) | Anna Frostegård | Other member of the company's administrative, management or supervisory body | Subscription | 3 007 628 | 0,25 | SEK | 751 907 | 2024-05-27 |
| 2024-05-30 | Annexin Pharmaceuticals AB (publ) | Mikael Lönn | Member of the Board of Directors | Acquisition | 46 652 346 | 0,25 | SEK | 11 663 086,5 | 2024-05-27 |
| 2024-06-05 | Annexin Pharmaceuticals AB (publ) | Mikael Lönn | Member of the Board of Directors | Acquisition | 1 477 343 | 0,25 | SEK | 369 335,75 | 2024-06-04 |
| 2024-06-08 | Annexin Pharmaceuticals AB (publ) | Curt Mikael von Euler-Chelpin | Member of the Board of Directors | Subscription | 240 000 | 0,25 | SEK | 60 000 | 2024-06-03 |
| 2024-06-13 | Annexin Pharmaceuticals AB (publ) | Nils Anders Haegerstrand | Chief Executive Officer (CEO)/Managing Directory | Subscription | 192 055 | 0,25 | SEK | 48 013,75 | 2024-06-11 |
| 2024-07-03 | Annexin Pharmaceuticals AB (publ) | Mikael Lönn | Member of the Board of Directors | Acquisition | 560 000 | 0,25 | SEK | 140 000 | 2024-07-02 |
| 2024-07-03 | Annexin Pharmaceuticals AB (publ) | Nils Anders Haegerstrand | Chief Executive Officer (CEO)/Managing Directory | Acquisition | 145 600 | 0,25 | SEK | 36 400 | 2024-07-02 |